Who Paid My Doc
BI 685509 Dose finding/PoCC in DKD
Research payments
$344,244
Through program year 2024, $344,244 in research payments was reported against BI 685509 Dose finding/PoCC in DKD, across 107 payments.
- Paid by (largest first)
- Boehringer Ingelheim Pharmaceuticals, Inc.; Boehringer Ingelheim Pharma GmbH & Co.KG
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $280,060 | 10 |
| 2021 | Research | $64,184 | 97 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Jose Cardona Miami, FL Named on 8 payments
- Lance Sloan Lufkin, TX Named on 7 payments
- Paul Crawford Evergreen Park, IL Named on 7 payments
- Robert Lynn Bronx, NY Named on 7 payments
- Vinayak Ramanath Lagrange, GA Named on 6 payments
- Kiranjit Dhillon Norfolk, VA Named on 6 payments
- Joseph Soufer Waterbury, CT Named on 6 payments
- Adam Frome The Woodlands, TX Named on 5 payments
- Robert Perry Pembroke Pines, FL Named on 5 payments
- Edgard Vera Tapia Victorville, CA Named on 5 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.